The use of alpha-blockers for benign prostatic hyperplasia is tied to an increased risk of developing acute angle-closure glaucoma, a study finds.
Woman's World on MSN
What Glaucoma Symptoms Look Like & Why They're Easy to Miss
It's one of the most common causes of vision loss, and one of the easiest to overlook. Glaucoma symptoms develop so gradually ...
Machine learning models can predict postoperative hyperopic shift in patients with primary angle-closure glaucoma.
In 2024, the American Law Institute (ALI) introduced a new standard for proving medical malpractice, replacing the ...
CHATHAM, N.J., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) ("Tonix” or the "Company”), a fully integrated commercial biotechnology company presented data on ...
Planning to initiate an open-label Phase 2 study of TNX-1500 under an investigator-initiated IND to evaluate safety and activity in the first half of 2026 ...
1 Department of Ophthalmology, Jinan Second People’s Hospital, Jinan, China 2 Nova Southeastern University College of Optometry, Miami, FL, United States Purpose: This study aimed to evaluate the ...
Recent Investor Day highlighted how AXPAXLI™ is positioned to redefine retina based on potential superiority label, market expansion, and ...
Detailed price information for Tonix Pharm Holdings (TNXP-Q) from The Globe and Mail including charting and trades.
Developed by Glaukos, the iDose TR (travoprost intraocular implant) 75 mcg is a new, FDA-approved treatment that is designed ...
Trial at 36 Months: 37% reduction in mean intraocular pressure (IOP) in evaluable patients across all dose groups with 95% of patients off all topical IOP-lowering drops100% of evaluable patients ...
Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully integrated, commercial biotechnology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback